CORT
Corcept Therapeutics Incorporated
NASDAQ: CORT · HEALTHCARE · BIOTECHNOLOGY
$46.59
-0.06% today
Updated 2026-04-29
Market cap
$5.00B
P/E ratio
56.82
P/S ratio
6.57x
EPS (TTM)
$0.82
Dividend yield
—
52W range
$29 – $91
Volume
1.8M
Corcept Therapeutics Incorporated (CORT) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-23.24M | $-10.96M | $-18.36M | $-17.97M | $-22.29M | $-27.40M | $-36.02M | $-37.06M | $-27.38M | $3.13M | $18.39M | $60.94M | $115.67M | $136.12M | $151.97M | $167.89M | $120.32M | $127.04M | $198.07M | $142.00M |
| Capital expenditures | $1.31M | $0.00 | $7000.00 | $7000.00 | $0.00 | $25000.00 | $151000.00 | $127000.00 | $174000.00 | $17000.00 | $194000.00 | $419000.00 | $298000.00 | $1.09M | $1.24M | $469000.00 | $413000.00 | $139000.00 | $2.17M | $211000.00 |
| Depreciation | $14000.00 | $13000.00 | $12000.00 | $10000.00 | $6000.00 | $3000.00 | $27000.00 | $74000.00 | $141000.00 | $155000.00 | $87000.00 | $106000.00 | $236000.00 | $2.17M | $2.24M | $3.07M | $3.45M | $2.36M | $1.34M | — |
| Stock-based comp | — | $1.06M | $1.62M | $1.80M | $2.12M | $3.44M | $5.31M | $5.20M | $5.20M | $6.01M | $7.06M | $13.36M | $23.75M | $29.31M | $33.54M | $42.93M | $42.44M | $48.94M | $61.35M | $84.50M |
| Free cash flow | $-24.55M | $-10.96M | $-18.37M | $-17.98M | $-22.29M | $-27.43M | $-36.17M | $-37.19M | $-27.55M | $3.11M | $18.20M | $60.52M | $115.37M | $135.03M | $150.73M | $167.42M | $119.91M | $126.90M | $195.90M | $141.78M |
| Investing cash flow | $25.36M | $-5.38M | $2.33M | $3.59M | — | $-25000.00 | $-151000.00 | $-127000.00 | $-174000.00 | $-17000.00 | $-194000.00 | $-73.46M | $-90.77M | $-117.83M | $-119.26M | $136.13M | $-114.33M | $90.91M | $-177.60M | — |
| Financing cash flow | $2.97M | $18.87M | $19.32M | $23.52M | $23.00M | $42.48M | $89.57M | $-970000.00 | $-3.08M | $13.07M | $-7.10M | $-7.95M | $-14.34M | $-28.64M | $12.21M | $-302.59M | $-17.28M | $-148.72M | $-28.35M | — |
| Dividends paid | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | $6.97M | $21.54M | $14.20M | $23.86M | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | $15.06M | $53.40M | $-38.16M | $-30.63M | $16.19M | $11.10M | $-20.47M | $10.56M | $-10.36M | $44.92M | $1.43M | — | — | — | — |